The Health Service Medical Supplies (Costs) Act 2017 has now been finalised. On the 26th April, members discussed a requirement for the government to promote the UK life science industry and ensure rapid access to new medicines. The Lords agreed with the Commons amendments and chose not to insist on its changes to the bill. Following agreement by both Houses on the text of the Bill it received Royal Assent on 27 April 2017. The Bill is now an Act of Parliament (law).
The aim of the act is to make provision in connection with controlling the cost of health service medicines and other medical supplies; to make provision in connection with the provision of pricing and other information by those manufacturing, distributing or supplying those medicines and supplies, and other related products, and the disclosure of that information; and for connected purposes.